Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castration-Resistant Prostate Carcinoma × testosterone enanthate × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Castration Resistant Metastatic Prostate Cancer 2 Prostatic Neoplasms 1 Castration-Resistant Prostate Carcinoma 1

Interventions

olaparib 2 tetracarboxyphenylporphine 1 testosterone enanthate 1 testosterone 17 beta-cypionate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Testosterone Propionate 1 Dexamethasone 1 Cyclophosphamide 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03516812 2025-09-29

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

University of Washington

Phase 2 Completed

36 enrolled 14 charts

Castration-Resistant Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡